Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
December 19, 2018
FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)
COPENHAGEN, Denmark, Dec. 19, 2018 /PRNewswire/ -- Veloxis Pharmaceuticals announced today that the U.S. Food & Drug Administration (FDA) approved a new indication for Envarsus XR ...
December 19, 2018
ADMA Biologics Provides Regulatory Update on BIVIGAM® PAS Submissions
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
December 17, 2018
Saniona’s tesofensine meets primary and secondary endpoints in Phase 3 obesity registration trial
Saniona (SANION.ST), a biotech company focused on CNS and eating disorders, today announced statistically and clinically significant weight loss for both doses of tesofensine compared ...
December 17, 2018
DURECT Corporation Announces Retirement of Dr. Felix Theeuwes as Chairman of the Board and Distinguished Scientist
CUPERTINO, Calif., Dec. 17, 2018 /PRNewswire/ -- DURECT Corporation (DRRX) announced today that Felix Theeuwes will retire as Chairman of the Board and Distinguished Scientist effective ...
December 17, 2018
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib for Treatment of Hepatitis Delta Virus (HDV) Infection
PALO ALTO, Calif., Dec. 17, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, ...
December 17, 2018
Arena Pharmaceuticals Appoints Experienced Life Sciences Industry Finance Executive Manmeet S. Soni to Board of Directors
SAN DIEGO, Dec. 17, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced the appointment of Manmeet S. Soni as a non-executive director. Mr. Soni is a highly ...
December 17, 2018
Acer Therapeutics Appoints Salma Jutt as Chief Commercial Officer
NEWTON, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
December 17, 2018
ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 10
LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (PRQR), a company dedicated to changing lives through the creation of ...
December 17, 2018
OSE Immunotherapeutics Appoints Julien Perrier Chief Commercial Officer
NANTES, France, Dec. 17, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA(ISIN: FR0012127173; Mnémo: OSE) today announced the appointment of Julien Perrier as chief commercial officer. ...
December 17, 2018
Transgene Announces Financial Calendar for 2019
STRASBOURG, France--(BUSINESS WIRE)-- Regulatory News: Transgene (TNG.PA) today announced its financial reporting dates for 2019: March 20: 2018 Fiscal Year Results May 13:  First Quarter ...
December 11, 2018
BioLineRx Announces Initiation of Triple Combination Arm of Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer Under Immuno-Oncology Collaboration
TEL AVIV, Israel, Dec. 11, 2018 /PRNewswire/ -- BioLineRx Ltd. (BLRX) (BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today the initiation ...
December 11, 2018
Entera Bio and Amgen Enter Strategic Research Collaboration in Inflammatory Disease and Other Serious Illnesses
JERUSALEM, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (ENTX) announced today that it has entered into a research collaboration and license agreement with ...
December 11, 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer™ as Published in JACC
VANCOUVER, Dec. 11, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN)(NVCN.TO), a leader in the development of minimally invasive transcatheter mitral valve replacement ...
December 11, 2018
STRATA Skin Sciences Secures Exclusive License for Treating Vitiligo Using an Excimer Laser
HORSHAM, Pa., Dec. 11, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
December 11, 2018
Cellectar Granted Japanese Patent for CLR 131
FLORHAM PARK, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
December 11, 2018
BELLUS Health Announces Pricing of $35 Million Public Offering of Common Shares
LAVAL, Quebec, Dec. 11, 2018 (GLOBE NEWSWIRE) -- BELLUS Health Inc. (BLU.TO) (BELLUS Health or the Company), a clinical-stage biopharmaceutical company developing novel therapeutics for ...
December 11, 2018
RedHill Biopharma Announces Closing of $20 Million Underwritten Offering
TEL-AVIV, Israel and RALEIGH, N.C., Dec. 11, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
December 11, 2018
Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer
Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced that its global ...
December 11, 2018
Eiger BioPharmaceuticals Reports on 2018 R&D Day
PALO ALTO, Calif., Dec. 11, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, today ...
December 11, 2018
Arrowhead Pharmaceuticals Reports Fiscal 2018 Year End Results
Arrowhead Pharmaceuticals Inc. (ARWR) today announced financial results for its fiscal 2018 fourth quarter and year ended September 30, 2018. The company is hosting a ...
Page 41 of 158